Right to Try and Ibogaine: What Trump’s Executive Order Actually Unlocks
Trump’s executive order does five specific things. It does not legalize ibogaine. A clear-eyed breakdown of what actually changes: Right to Try pathway, National Priority Voucher review, investigational new drug clearance, $50M state research, and the realistic timeline for legal US clinics.
Ibogaine Cardiac Safety: The Real Risk Profile and How Legitimate Clinics Handle It
Ibogaine has real cardiac risks. They are manageable. Most of the deaths in the literature occurred in unmonitored settings without screening. A clear-eyed breakdown of the QT prolongation mechanism, what legitimate clinics do, and the exact checklist that would have flagged the tragedy that put Ameen Alai in prison.
Guru Ameen Starts 48 Months for Ibogaine — And Within 6 Months, RFK Jr. Will Make Everything He Did Legal
Ameen got 48 months. The federal judge declared ibogaine ‘more dangerous than fentanyl’ on the sentencing record. The same month Texas launched a $50 million ibogaine research program and Netflix dropped a documentary showing Navy SEALs credit the molecule with saving their lives. My prediction, on the record: within six months, the Trump administration issues executive action. And then we fight for the pardon.
The Compound That Cured My Brain Fog in 30 Days: My Microdose Ibogaine Experiment Under Guru Ameen
I’ve been microdosing ibogaine under my friend Guru Ameen Alai’s direct supervision for the past year. Here’s what six years of knowing him, thirty days of protocol, and one federal indictment have taught me about the most undervalued molecule in addiction medicine.
They’re Trying to Crucify Guru Ameen for Healing People: Stanford Just Proved He Was Right
Fifteen months after I first wrote about my friend Guru Ameen’s federal case, the ‘resulting in death’ charge has collapsed — exactly as I predicted. Meanwhile, Stanford just published an 88% PTSD reduction result with ibogaine in combat veterans, and an unprecedented political coalition is forming. The dam is about to break.
What Is Ibogaine? The Complete Guide to the West African Shrub About to Get FDA Approval
Ibogaine, the West African plant medicine Trump just fast-tracked for FDA approval, has a 2,000-year history treating addiction and trauma. The complete guide to the alkaloid, the Bwiti tradition, the pharmacology, the risks, and why the medical establishment spent 60 years ignoring what indigenous healers already knew.
The Price of Being First: Tony Huge, the Peptide Industry, and the Pattern of Punished Pioneers
Tony Huge helped build the modern peptide industry — and paid for being early. The pattern repeats across medical history: Semmelweis committed to an asylum for handwashing, Galileo tried for heresy, Barry Marshall drinking bacteria to prove ulcers are infectious, Prusiner called a heretic for twenty years before the Nobel. Eight YouTube channels and twenty+ Instagram accounts removed. This article is the record.
Trump Just Legalized the Road to Ibogaine Approval. Ameen Alai Is Still in Prison for It.
On April 18, 2026, Trump signed an executive order fast-tracking FDA review of ibogaine for addiction and PTSD, with Rogan, RFK Jr., and Americans for Ibogaine CEO Bryan Hubbard in the Oval Office. FDA Commissioner Makary confirmed approval could come in 60 days. Meanwhile Ameen Alai sits in federal prison serving 48 months for distributing the exact compound the federal government now calls a national priority. The case for clemency writes itself.
LGD-4033 (Ligandrol): Honest Breakdown of the Bulking SARM
Quick Summary What it is: LGD-4033 (Ligandrol, VK5211) is a selective androgen receptor modulator with ~500:1 anabolic-to-androgenic tissue selectivity toward muscle and bone. Mechanism: High-affinity partial agonist at the androgen receptor — Ki around 1 nM in muscle tissue, minimal prostate or sebaceous gland activation. Who it’s for: Lifters who want cleaner muscle accrual without […]
CJC-1295 + Ipamorelin: The GH Stack That Actually Works
Quick Summary What it is: CJC-1295 is a growth hormone releasing hormone (GHRH) analog; Ipamorelin is a selective ghrelin receptor (GHSR-1a) agonist. Run together they produce pulsatile gh release that mimics the body’s native pattern. Mechanism: Two independent inputs to the pituitary somatotroph — the ghRH arm (CJC) tells the cell to release GH, the […]